Sai Life Sciences Commences Recruitment of 300+ Scientists for its Upcoming Integrated Research & Technology Centre in Hyderabad

/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced that it has initiated the recruitment of 300+ scientists for its upcoming integrated Research & Technology (R&T) centre in Hyderabad, India. This will result in doubling the full-time equivalents (FTEs) in the areas of discovery chemistry, process chemistry and analytical chemistry.

Making the announcement, Krishna Kanumuri, CEO & MD, Sai Life Sciences said, "We are at a very exciting point in our journey and are looking to expand our team of highly-motivated scientists. This will help us better serve our customers by accelerating their projects involving complex chemistry and next generation technologies."
About Sai Life Sciences
Sai Life Sciences is a full-service CDMO driven by a vision to support the launch of 25 new medicines by 2025. It works with innovator pharma and biotech companies globally, accelerating the discovery, development and manufacture of complex small molecules. A pure-play CDMO, Sai Life Sciences has served a diverse set of NCE development programs, consistently delivering value based on its quality and responsiveness. Today, it works with 7 of the top 10 large pharma companies, as well as several small and mid-sized pharma & biotech companies. Sai Life Sciences is privately held and backed by global investors, TPG Capital and HBM Healthcare Investments. www.sailife.com
Logo: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg